Products
| Brand name | Generic name | Product type | Indication | Product Information | Consumer Medicine Information | Available |
|---|---|---|---|---|---|---|
| AndroFeme® 1 | Testosterone | Topical cream for Women | Hypoactive sexual desire dysfunction (HSDD) in postmenopausal women | PI | CMI | Nationally |
| AndroForte® 5 | Testosterone | Topical cream for men – Scrotal or Upper Body application | Confirmed testosterone deficiency in men | PI | CMI | Nationally |
| ProFeme® | Progesterone | Topical cream | For use in women | PI | CMI | Western Australia |
Using the Dose Applicator Demonstration Video
Latest News
In Australia, is Addyi (Flibanserin) available or what is available?
Australia Leads the Way in Androgen Treatment for Women with HSDD While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s… Continue Reading →
How Satisfied are you with Your Sex Life?
Let’s Talk About Sexual Satisfaction—It Matters More Than You Think Did you know that 4 in 10 women experience sexual concerns during mid-life? Yet many suffer… Continue Reading →
MHRA approves testosterone cream for UK postmenopausal women
MHRA approves testosterone cream for UK postmenopausal women 12 August 2025 Perth, Australia and Guildford, England: Lawley Pharmaceuticals and its commercial… Continue Reading →